TECHNOLOGY

Advanced Biologics was initially formed in 2009 when it introduced the innovative OsteoAMP® product line to the orthopaedic and neurosurgery markets.  OsteoAMP was divested in 2014 to Bioventus

 

Subsequent technology introductions include a cellular bone matrix, OsseoGEN™, and an allograft derived growth factor, ProteiOS®.  Both currently being distributed by Biologica Technologies.

OsseoGEN-Logo_4C.transparent.png

OsseoGEN is Advanced Biologics' cell based allograft matrix distributed by Biologica Technologies.  For additional information, click on this link.

ProteiOS_Registered_TM_transparent.png

ProteiOS is Advanced Biologics' allograft derived growth factor distributed by Biologica Technologies.  For additional information, click on this link.

oie_transparent (7) (1).png